Evidence map›Paper›PMID 40860992›Full record

ArticleRegenerative biomaterials2025

A novel paclitaxel eluting bioresorbable vascular stent with a super flexible stent structure and round cross section struts fabricated using 3D printing technology with a rotating platform.

Wei Liu, Qingqing Li, Ge Song, Zhiqi Lin, Xiaofei Gong, Hanqing Feng, Hugh Q Zhao, Yujie Zhou, Yunbing Wang, Zhongyong Fan and 1 more

Abstract read
In one paragraph

Article in Regenerative biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Application of PLCL as a biodegradable polymer in biomedical engineering.Journal of materials science. Materials in medicine · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wei LiuCardiovascular Department, Jishuitan Hospital, Beijing, 100035, P. R. China.
Qingqing LiBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Ge SongBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Zhiqi LinBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Xiaofei GongBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Hanqing FengBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Hugh Q ZhaoBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.
Yujie ZhouBeijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P.R. China.
Yunbing WangCollege of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, 610065, P. R. China.
Zhongyong FanDepartment of Materials Science, Fudan University, Shanghai 200433, P. R. China.
Qing LiuBeijing Advanced Medical Technologies, Ltd Inc, Beijing 102600, P. R. China.ORCID https://orcid.org/0000-0001-7537-3088

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioresorbable stents (BRS) have emerged as a groundbreaking development in the field of percutaneous coronary intervention (PCI) as they address the long-standing concerns of metallic stents. Nevertheless, the observed higher thrombosis rates in the first generation BRS, i.e. ABSORB

Indexed as

3D printingbioresorbable stentcoronary stentpaclitaxel drug releasepoly(L-lactide-co-ɛ-caprolactone) copolymer

Identifiers

PMID40860992
PMCPMC12371334

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.